Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated CancersVan K. Morris, Michael Frumovitz, Curtis A. Pettaway et al.|The Oncologist|2023Cited by 29
Phase II trial of MEDI0457 and durvalumab for patients with recurrent/metastatic HPV-associated cancers.Van K. Morris, Amir A. Jazaeri, Shannon N. Westin et al.|Journal of Clinical Oncology|2021Cited by 8